Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Prescription Drugs
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Perspective (2018-2034)
2.2 Non-24-hour Sleep-wake Disorder Treatment Growth Trends by Region
2.2.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Region (2018-2023)
2.2.3 Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Region (2024-2034)
2.3 Non-24-hour Sleep-wake Disorder Treatment Market Dynamics
2.3.1 Non-24-hour Sleep-wake Disorder Treatment Industry Trends
2.3.2 Non-24-hour Sleep-wake Disorder Treatment Market Drivers
2.3.3 Non-24-hour Sleep-wake Disorder Treatment Market Challenges
2.3.4 Non-24-hour Sleep-wake Disorder Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Revenue
3.1.1 Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Revenue (2018-2023)
3.1.2 Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Non-24-hour Sleep-wake Disorder Treatment Revenue
3.4 Global Non-24-hour Sleep-wake Disorder Treatment Market Concentration Ratio
3.4.1 Global Non-24-hour Sleep-wake Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2024
3.5 Non-24-hour Sleep-wake Disorder Treatment Key Players Head office and Area Served
3.6 Key Players Non-24-hour Sleep-wake Disorder Treatment Product Solution and Service
3.7 Date of Enter into Non-24-hour Sleep-wake Disorder Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-24-hour Sleep-wake Disorder Treatment Breakdown Data by Type
4.1 Global Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Type (2018-2023)
4.2 Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Type (2024-2034)
5 Non-24-hour Sleep-wake Disorder Treatment Breakdown Data by Application
5.1 Global Non-24-hour Sleep-wake Disorder Treatment Historic Market Size by Application (2018-2023)
5.2 Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2034)
6.2 North America Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)
6.4 North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2034)
7.2 Europe Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)
7.4 Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2034)
8.2 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2034)
9.2 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)
9.4 Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size (2018-2034)
10.2 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Detail
11.1.2 Teva Business Overview
11.1.3 Teva Non-24-hour Sleep-wake Disorder Treatment Introduction
11.1.4 Teva Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.1.5 Teva Recent Development
11.2 Mylan
11.2.1 Mylan Company Detail
11.2.2 Mylan Business Overview
11.2.3 Mylan Non-24-hour Sleep-wake Disorder Treatment Introduction
11.2.4 Mylan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.2.5 Mylan Recent Development
11.3 Nature’s Bounty
11.3.1 Nature’s Bounty Company Detail
11.3.2 Nature’s Bounty Business Overview
11.3.3 Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Introduction
11.3.4 Nature’s Bounty Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.3.5 Nature’s Bounty Recent Development
11.4 Otsuka Pharma (Pharmavite)
11.4.1 Otsuka Pharma (Pharmavite) Company Detail
11.4.2 Otsuka Pharma (Pharmavite) Business Overview
11.4.3 Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Introduction
11.4.4 Otsuka Pharma (Pharmavite) Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.4.5 Otsuka Pharma (Pharmavite) Recent Development
11.5 Boiron
11.5.1 Boiron Company Detail
11.5.2 Boiron Business Overview
11.5.3 Boiron Non-24-hour Sleep-wake Disorder Treatment Introduction
11.5.4 Boiron Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.5.5 Boiron Recent Development
11.6 Miers Laboratories
11.6.1 Miers Laboratories Company Detail
11.6.2 Miers Laboratories Business Overview
11.6.3 Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Introduction
11.6.4 Miers Laboratories Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.6.5 Miers Laboratories Recent Development
11.7 Genexa
11.7.1 Genexa Company Detail
11.7.2 Genexa Business Overview
11.7.3 Genexa Non-24-hour Sleep-wake Disorder Treatment Introduction
11.7.4 Genexa Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.7.5 Genexa Recent Development
11.8 Homeocan
11.8.1 Homeocan Company Detail
11.8.2 Homeocan Business Overview
11.8.3 Homeocan Non-24-hour Sleep-wake Disorder Treatment Introduction
11.8.4 Homeocan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.8.5 Homeocan Recent Development
11.9 Clinigen Group
11.9.1 Clinigen Group Company Detail
11.9.2 Clinigen Group Business Overview
11.9.3 Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Introduction
11.9.4 Clinigen Group Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.9.5 Clinigen Group Recent Development
11.10 Vanda Pharma
11.10.1 Vanda Pharma Company Detail
11.10.2 Vanda Pharma Business Overview
11.10.3 Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Introduction
11.10.4 Vanda Pharma Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
11.10.5 Vanda Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Prescription Drugs
Table 3. Key Players of OTC
Table 4. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Region (2018-2023)
Table 8. Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Region (2024-2034)
Table 10. Non-24-hour Sleep-wake Disorder Treatment Market Trends
Table 11. Non-24-hour Sleep-wake Disorder Treatment Market Drivers
Table 12. Non-24-hour Sleep-wake Disorder Treatment Market Challenges
Table 13. Non-24-hour Sleep-wake Disorder Treatment Market Restraints
Table 14. Global Non-24-hour Sleep-wake Disorder Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Players (2018-2023)
Table 16. Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-24-hour Sleep-wake Disorder Treatment as of 2024)
Table 17. Ranking of Global Top Non-24-hour Sleep-wake Disorder Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Non-24-hour Sleep-wake Disorder Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Non-24-hour Sleep-wake Disorder Treatment Product Solution and Service
Table 21. Date of Enter into Non-24-hour Sleep-wake Disorder Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Type (2024-2034)
Table 27. Global Non-24-hour Sleep-wake Disorder Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Non-24-hour Sleep-wake Disorder Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Non-24-hour Sleep-wake Disorder Treatment Revenue Market Share by Application (2024-2034)
Table 31. North America Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 46. Teva Company Detail
Table 47. Teva Business Overview
Table 48. Teva Non-24-hour Sleep-wake Disorder Treatment Product
Table 49. Teva Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)
Table 50. Teva Recent Development
Table 51. Mylan Company Detail
Table 52. Mylan Business Overview
Table 53. Mylan Non-24-hour Sleep-wake Disorder Treatment Product
Table 54. Mylan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)
Table 55. Mylan Recent Development
Table 56. Nature’s Bounty Company Detail
Table 57. Nature’s Bounty Business Overview
Table 58. Nature’s Bounty Non-24-hour Sleep-wake Disorder Treatment Product
Table 59. Nature’s Bounty Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)
Table 60. Nature’s Bounty Recent Development
Table 61. Otsuka Pharma (Pharmavite) Company Detail
Table 62. Otsuka Pharma (Pharmavite) Business Overview
Table 63. Otsuka Pharma (Pharmavite) Non-24-hour Sleep-wake Disorder Treatment Product
Table 64. Otsuka Pharma (Pharmavite) Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)
Table 65. Otsuka Pharma (Pharmavite) Recent Development
Table 66. Boiron Company Detail
Table 67. Boiron Business Overview
Table 68. Boiron Non-24-hour Sleep-wake Disorder Treatment Product
Table 69. Boiron Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)
Table 70. Boiron Recent Development
Table 71. Miers Laboratories Company Detail
Table 72. Miers Laboratories Business Overview
Table 73. Miers Laboratories Non-24-hour Sleep-wake Disorder Treatment Product
Table 74. Miers Laboratories Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)
Table 75. Miers Laboratories Recent Development
Table 76. Genexa Company Detail
Table 77. Genexa Business Overview
Table 78. Genexa Non-24-hour Sleep-wake Disorder Treatment Product
Table 79. Genexa Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)
Table 80. Genexa Recent Development
Table 81. Homeocan Company Detail
Table 82. Homeocan Business Overview
Table 83. Homeocan Non-24-hour Sleep-wake Disorder Treatment Product
Table 84. Homeocan Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)
Table 85. Homeocan Recent Development
Table 86. Clinigen Group Company Detail
Table 87. Clinigen Group Business Overview
Table 88. Clinigen Group Non-24-hour Sleep-wake Disorder Treatment Product
Table 89. Clinigen Group Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)
Table 90. Clinigen Group Recent Development
Table 91. Vanda Pharma Company Detail
Table 92. Vanda Pharma Business Overview
Table 93. Vanda Pharma Non-24-hour Sleep-wake Disorder Treatment Product
Table 94. Vanda Pharma Revenue in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023) & (US$ Million)
Table 95. Vanda Pharma Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Type: 2024 VS 2034
Figure 3. Prescription Drugs Features
Figure 4. OTC Features
Figure 5. Global Non-24-hour Sleep-wake Disorder Treatment Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 6. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Application: 2024 VS 2034
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Other Case Studies
Figure 10. Non-24-hour Sleep-wake Disorder Treatment Report Years Considered
Figure 11. Global Non-24-hour Sleep-wake Disorder Treatment Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global Non-24-hour Sleep-wake Disorder Treatment Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Region: 2024 VS 2034
Figure 14. Global Non-24-hour Sleep-wake Disorder Treatment Market Share by Players in 2024
Figure 15. Global Top Non-24-hour Sleep-wake Disorder Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-24-hour Sleep-wake Disorder Treatment as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by Non-24-hour Sleep-wake Disorder Treatment Revenue in 2024
Figure 17. North America Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2018-2034)
Figure 19. United States Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Canada Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2018-2034)
Figure 23. Germany Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. France Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. U.K. Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Italy Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Russia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Nordic Countries Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Non-24-hour Sleep-wake Disorder Treatment Market Share by Region (2018-2034)
Figure 31. China Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Japan Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. South Korea Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Southeast Asia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. India Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Australia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2018-2034)
Figure 39. Mexico Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Brazil Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Non-24-hour Sleep-wake Disorder Treatment Market Share by Country (2018-2034)
Figure 43. Turkey Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Saudi Arabia Non-24-hour Sleep-wake Disorder Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Teva Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
Figure 46. Mylan Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
Figure 47. Nature’s Bounty Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
Figure 48. Otsuka Pharma (Pharmavite) Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
Figure 49. Boiron Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
Figure 50. Miers Laboratories Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
Figure 51. Genexa Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
Figure 52. Homeocan Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
Figure 53. Clinigen Group Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
Figure 54. Vanda Pharma Revenue Growth Rate in Non-24-hour Sleep-wake Disorder Treatment Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed